caries, parodontitis apicalis, adult parodon titis
Conditions
Interventions
Continuation of anti-platelet agents during the ten days prior to the procedure.
Sponsors
Academic Medical Center, department of Oral Maxillofacial Surgery,
Academic Medical Center, department of Internal Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient on antiplatelet therapy who has to be treated in the AMC at the Department of Oral and Maxillofacial surgery; 2. Approval of the prescribing physician; 3. At least 18 years old.
Exclusion criteria
Exclusion criteria: 1. Known coagulation defect; 2. Use of oral anticoagulant treatment (vitamin K antagonists) or therapeutic heparin; 3. Severe kidney dysfunction (creatinin clearance < 20 ml/min) or hepatic dysfunction; 4. Unstable coronary artery disease; 5. Patients younger than 18 years of age; 6. Refusal to provide informed consent; 7. Recent placement of a coronary stent (during the last 6 month).
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome is the occurrence of thrombo-embolic events at 30 days follow-up. The predictive effect of measurements in DNA, blood and saliva on peri-procedural hemostasis and blood loss is also a secondary endpoint. | — |
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study is peri-procedural blood loss. | — |
Contacts
Public ContactM.H. Frank
Academic Medical Center (AMC), Department of Oral- and Maxillofacial Surgery, P.O. Box 22660
Outcome results
None listed